ArticleAntibody therapeutics2026

RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy.

Masanori Onda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.